2020
DOI: 10.4103/jmp.jmp_53_20
|View full text |Cite
|
Sign up to set email alerts
|

Influence of air gap under bolus in the dosimetry of a clinical 6 MV photon beam

Abstract: Aim: In some situations of radiotherapy treatments requiring application of tissue-equivalent bolus material (e.g., gel bolus), due to material's rigid/semi-rigid nature, undesirable air gaps may occur beneath it because of irregularity of body surface. The purpose of this study was to evaluate the dosimetric parameters such as surface dose (D s ), depth of dose maximum (d max ), and depth dose along central axis derived from the percentage dep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Srinivas et al evaluated dosimetric parameters such as depth dose along the central axis using a 6 MV clinical photon beam in the presence of air gaps between the gel bolus and the treatment surface. They reported that the surface dose decreased as the air gap increased in the presence of a 0.5 cm bolus and a 10x10 cm 2 beam field [14].…”
Section: Resultsmentioning
confidence: 99%
“…Srinivas et al evaluated dosimetric parameters such as depth dose along the central axis using a 6 MV clinical photon beam in the presence of air gaps between the gel bolus and the treatment surface. They reported that the surface dose decreased as the air gap increased in the presence of a 0.5 cm bolus and a 10x10 cm 2 beam field [14].…”
Section: Resultsmentioning
confidence: 99%
“…Scanned images should be analyzed to ensure minimal air gaps. A threshold should be established for in‐house air gap tolerance based on acceptable dosimetric uncertainty 53–57 . The treatment plan, designed in the earlier stages of the bolus fabrication, must be verified prior to clinical use by performing a final dose calculation using the re‐simulated CT scan of the patient with the printed bolus in place.…”
Section: Quality Assurancementioning
confidence: 99%
“…A threshold should be established for in-house air gap tolerance based on acceptable dosimetric uncertainty. [53][54][55][56][57] The treatment plan, designed in the earlier stages of the bolus fabrication, must be verified prior to clinical use by performing a final dose calculation using the re-simulated CT scan of the patient with the printed bolus in place. One study has explored the QA tolerance levels for 3D printed boluses for VMAT treatment of the nose, and recommended 5% for density variation, 1 mm for thickness variation, and 5 mm for air gap.…”
Section: 11mentioning
confidence: 99%